Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 55.80
+2.70 (5.08%)
May 30, 2025, 3:00 PM CST
SHA:688621 Revenue
Beijing Sun-Novo Pharmaceutical Research had revenue of 230.84M CNY in the quarter ending March 31, 2025, a decrease of -8.49%. This brings the company's revenue in the last twelve months to 1.06B, up 11.04% year-over-year. In the year 2024, Beijing Sun-Novo Pharmaceutical Research had annual revenue of 1.08B with 15.70% growth.
Revenue (ttm)
1.06B
Revenue Growth
+11.04%
P/S Ratio
5.77
Revenue / Employee
679.34K
Employees
1,556
Market Cap
6.10B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |